The Art of Balance: Sugars and Holiday Food
Celebrating the Holidays can be a challenge if you or one of your family members has diabetes. Explore some helpful tips for preparing your…
This study is looking for patients with Type 2 Diabetes who are currently using Lantus or Basaglar. Patients will either remain on their insulin or will have a once-weekly study injection added to reduce the amount of insulin taken.
The once-weekly study injection is already approved on the market.
Study participants may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Services
Director of Clinical Research
Clinical Research Coordinator
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator